Antioxidant and NMDA Receptor Blocker Wins Anoxic Brain Damage of KorEa OHCA Patients
Clinical trial NCT03651557 · UNKNOWN
Trial details
- NCT number
- NCT03651557
- Sponsor
- GNT Pharma
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-29
- Primary completion
- 2021-05-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.